NCT05872854 2026-02-09
RW-HPN-MF-01
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
Clinical Trials
6 trialsNCT06113081 2025-12-24
FIL_MOGA
Fondazione Italiana Linfomi - ETS
Completed
NCT07235813 2025-11-19
IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy
Kasr El Aini Hospital
Phase NA Completed
NCT04074746 2025-09-30
Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT06149247 2025-08-20
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Soligenix
Phase 2 Completed
NCT00368784 2025-05-14
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
University of California, Davis
Completed